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     Curcumin is a natural polyphenolic compound with anti-cancer, anti-inflammatory, and anti-oxidation 
properties. Low water solubility and rapid hydrolytic degradation are two challenges limiting use of 
curcumin as therapeutic agent. In the current study, the role of the Bovine Serum Albumin (BSA), β-
lactoglobulin and casein, as food-grade biopolymers and safe drug delivery systems, on the physical 
activity of curcumin were surveyed. It appears that BSA and casein as protein vehicles are useful tools to 
increase stability of curcumin, as a health promoting agent.  
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INTRODUCTION 
     According to the International Food 
Information Council (IFIC) “functional food” is 
defined as “food that has health promotion 
properties beyond basic nutrition”. In this way, 
different phytochemicals especially polyphenols 
have attracted the attention and extensive 
research has been carried out to devise novel 
methods to incorporate the functional 
ingredients into foods. Curcumin (1,7-bis(4-
hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-
dione) is the best characterized plant-derived 
polyphenol showing chemopreventive and 
safety activities against malignancy [1].  
This yellow-orange natural compound which is 
the main component of Curcuma longa 
rhizomes (Figure. 1), has been consumed as 
dye, food additive and potential therapeutic 
(Figure. 2) for a long time period in Asia [2]. In 
the past decade, scientific studies have revealed 
other medicinal effects of curcumin including 
anti-proliferative, anti-angiogenic, anti-
inflammatory, anti-cystic fibrosis, anti-oxidant 
and wound healing properties [3, 4] (Figure. 2). 
Due to low intrinsic toxicity of curcumin for 
healthy (normal) cells, several clinical trials are 
either underway or have been completed with 
an aim to develop curcumin into a treatment 
agent [2, 5, 6]. Curcumin is extremely safe even 
at very high doses of 8–12 g/day [5, 6]. But, 
from the chemical viewpoint, there are several 
challenges that must be overcome for curcumin 
to become a routine treatment agent: Despite the 
safety, efficacy and well-tracked mechanisms of 
action, curcumin has a low aqueous solubility 
(approximately 11 ng/mL), which significantly 
limits its bioavailability in vivo [3, 5-7]. On the 
other hand, in aqueous medium, curcumin 
undergoes rapid degradation by hydrolysis 
(even at physiological pH) followed by 
molecular fragmentation within 30 min [7-9] 
(Figure. 3). Various approaches have been 
applied to increase water solubility, stability and 
bioavailability of curcumin such as 
emulsification, chemical modification, and 
encapsulation in polymer nanoparticles, 
cyclodextrins, hydrogels and nanogels, 
polymeric and surfactants micelles, lipid 
bilayers, liposome/phospholipid, solid lipid 
nanoparticles, polymer conjugates, self-
assemblies, and vesicles and other delivery 
systems [10]. For instance, the water solubility 
of curcumin in cyclodextrin-based or 
chemically modified systems can reach about 2-
200 mg/ml [11-13]. However, each delivery 
system may have cytotoxic effects on some 
normal tissues and cells and/or display limited 
influence on curcumin stability.  


























Figure 1. (Top, Left) Curcuma Longa with flower and rhizome. Turmeric (Curcuma longa L.), belonging to the family 
of Zingiberaceae, is a perennial herb native to India where its rhizome is used as a yellow colorant curry spice and 
traditional medicine. (Bottom) Turmeric color at different conditions and dried pure curcumin. (Top, Right) Chemical 
structure of turmeric constituent compounds. The active principle in turmeric was identified as a group of polyphenolic 
compounds, namely curcumin (74-78%), demethoxycurcumin (15-18%) and bisdemethoxycurcumin (4-6%) commonly 
referred to as “curcumin”.   
 
Figure 2. Curcumin is a potential therapeutic for various types of clinical diseases.  




Figure 3. Chemical structures of curcumin and its degradation products. Due to low stability, curcumin degrades under 
physiological conditions. The degradation products have been identified as trans-6-(40-hydroxy-30-methoxyphenyl)-2,4-
dioxo-5-hexenal, ferulic aldehyde, ferulic acid, feruloyl methane and vanillin. 
 
 
Drug delivery systems based on food proteins 
hold much promise because of their high 
nutritional value, low toxicity and excellent 
functional properties as well as their 
applications as ingredients in the food industry. 
The main aim of the current study is to 
introduce β-lactoglobulin, albumin and casein 
(Fig. 4) as food-grade amphiphilic materials to 
interact with curcumin, since these proteins 
(especially serum albumins and caseins) are 
commonly used transporting vehicles for 
proteins, hormones, drugs, and diagnostic 
agents [14].  
Moreover, for several years, Haldi doodh 
(turmeric milk and/or warm milk mixed with 
some turmeric powder) is commonly used in 
India as a home remedy when someone is 
suffering from fever. Turmeric paste is often 
used in India as an antiseptic in open wounds, 
while chun-holud (turmeric with slaked lime) is 
used to stop bleeding as home remedies [15]. 
Casein micelles (major proteins in milk) are 
relatively easy to prepare, biodegradable, and 
have potential for high drug loading capacity. 
Serum albumin is the most abundant of the 
proteins, circulated several times in the blood 
[16]. Both casein micelles and albumin delivery 
systems have been previously employed for 
administration of several hydrophobic drugs 
[17, 18]. Beta-casein is also an amphiphilic self-
assembling protein that helps to solubilize 
curcumin more efficiently in aqueous solution 
[11]. β-lactoglobulin, a small globular protein 
with 162 amino acid residues is also the major 
whey protein in bovine milk. It is classified as a 
member of the lipocalin-protein family because 
of its high affinity to small hydrophobic ligands 
[19]. Taking both traditional medicine and 
literature into account, there is possibility that 
stability characteristics of curcumin improves 
upon binding to mentioned proteins. To test this 
possibility, the current study has focused on the 
protective effects of accompanying proteins on 
light- and water-mediated degradation of 
curcumin. This work is particularly novel and 
significant because to the best of our 
knowledge, no previous similar studies have 
been reported about protective effect of proteins 
against light-mediated degradation of curcumin. 
We found that proteins slow down the rate of 
curcumin degradation compared to the free 
curcumin.  We report that while no curcumin 
stabilization takes place in the presence of β-
lactoglobulin, it is greatly stabilized in the 
presence of BSA. The results also imply that the 
association of curcumin to casein contributes 
significantly to its stability in Indian (home) 
therapeutic preparations. 
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Figure 4. Ribbon  representation  of  BSA  (left, ID  code  2BXB)) and  β-lactoglobulin (middle, ID  code  1BEB)  as 
well as a proposed model of casein micelles (right).  For  interpretation  of  the  references  to  color  in  this  figure  
legend,  the  reader  is  referred  to  the  web version  of  this  article. 
 
 
MATERIALS AND METHODS 
Materials 
    Bovine serum albumin, β-lactoglobulin and 
casein provided from Sigma and phosphate 
buffer, curcumin and the other reagents were 
analytical grade and purchased from Merck. 
All experiments were repeated at least 3 times. 
Methods 
Water-mediated degradation. After excitation 
at 420 nm, fluorescence emission spectra of 
curcumin        (10µM) in the absence and the 
presence of each protein (40µM) in phosphate 
buffer (20mM and pH=7) at 37 
⁰
C were 
recorded from 440 to 700 nm during 60 min 
with 3 min intervals. The background 
fluorescence was subtracted from each 
emission spectrum.  
Light-mediated degradation. Absorption of 
curcumin (10µM) in the absence and the 
presence of each protein (40µM) were 
recorded at 420 nm in darkness and front of the 
direct light during 9 hours. 
 
RESULTS 
    To investigate effect of solvent, curcumin 
degradation was evaluated in the presence of 
an aqueous (water) as well as a non-aqueous 
(absolute ethanol) solvent (Figure. 5). As 
shown in Figure. 5, ethanol does not degrade 
curcumin whereas water remarkably 
decomposes it. Moreover, light accelerate the 
curcumin degradation rate especially in the 
aqueous medium. 
To test of protective effects of BSA, casein, 
and β-lactoglobulin on curcumin degradation, 
the kinetic of water-mediated curcumin 
degradation was investigated in the presence of 
proteins. In phosphate buffer solution, the 
degradation is accompanied by a substantial 
decrease in the fluorescence emission intensity. 
By plotting of the maximum emission intensity 
of spectra against time, the kinetic profiles of 
curcumin decomposition were obtained 
(Figure. 6). BSA and casein improves the 
curcumin stability while β-lactoglobulin 
increases the curcumin degradation rate, 
significantly. 
There is this possibility that employed proteins 
protect curcumin against light-mediated 
degradation. The kinetic profiles of curcumin 
light-mediated degradation were created by 
plotting of the absorbance at 420 nm versus 
time. As can be seen in Figure. 7, BSA and 
casein decrease the curcumin degradation rate 
whereas β-lactoglobulin unstable the curcumin. 
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Figure 5. Effect of water activity and light on the curcumin stability, at room temperature.  
 
 
Figure. 6. Curcumin stability in the presence of BSA (filled circle), β-lactoglobulin (filled square), casein (filled triangle) 
and in buffer alone (pH 7, asterisk), at 37 °C. 
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Figure 7. Effect of three proteins; BSA (filled circle), β-lactoglobulin (filled square), casein (filled triangle) on the curcumin 
stability against direct light, at 37 °C, Buffer alone (pH 7, asterisk). 
 
DISCUSSION 
    Curcumin, with considerable pharmaceutical 
activity, is a hydrophobic polyphenolic 
compound with low water solubility and 
stability [1, 7]. Hence, curcumin requires a 
convenient carrier system to deliver to 
different parts of the body. Recently, various 
systems such as encapsulation in nanoparticles, 
cyclodextrins, micelles, and proteins are being 
expanded for drug delivery investigations [3, 
10]. In this study, the stability characteristics 
of curcumin in the presence of various proteins 
have been studied. Previous studies have 
shown that alkaline hydrolysis is the main 
process in the degradation of curcumin in 
buffer solution [3]. Curcumin is partially 
deprotonated initially, which is followed by 
fragmentation into trans-6-(4´-hydroxy-3´-
methoxyphenyl)-2,4-dioxo-5-hexanal [8]. This 
product is then further decomposed into 
smaller molecules such as vanillin, feruloyl 
methane, and ferulic acid [3, 8]; these 
molecules contribute negligibly to the 
absorption of 420 nm light. 
As indicated in Fig. 5, curcumin remains intact 
in the presence of ethanol while it decomposes 
significantly in the polar medium. In other 
word, both light and water activity accelerate 
curcumin degradation rate. Additionally, 
curcumin degradation rate has been evaluated 
in the presence of two polarity reducing 
compounds, ethylene glycol (EG) and 
polyethylene glycol 6000 (PEG). The results 
showed that these two compounds has similar 
protective effects so that they reduced 
curcumin degradation rate by almost 10-fold 
(86% and 98%, respectively, data not shown). 
This is probably due to the weak and dynamic 
hydrophobic interactions between the exposed 
hydrophobic regions of polarity reducing 
agents and curcumin. 
Investigation of the degradation of curcumin in 
the presence of BSA, casein and βLG is of 
interest as these food-grade proteins are 
believed to act as natural transporting 
molecules. Figure. 6 shows the intact curcumin 
decays to approximately 30% of the initial 
value in 60 min. In contrast, the curcumin 
water-mediated degradation is negligible in the 
presence of BSA and casein. Similar to kinetic 
of water-mediated degradation, albumin and 
casein also show capability to protect curcumin 
against light-mediated degradation while β-
lactoglobulin promotes curcumin 
decomposition by unknown mechanism 
(Figuer. 7).  
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There are several reports on the binding of 
curcumin to the serum albumin and casein [2, 
3, 20]. It seems to be stabilization of curcumin 
in the presence of BSA and casein, as indicated 
in this study, is due to interaction between 
proteins and curcumin. This supposition is 
confirmed by pervious study which indicates 
the plasma proteins (human serum albumin and 
fibrinogen) interact with curcumin and 
stabilize it against hydrolytic degradation [3]. 
Overall, Our results along with previous 
reports clearly highlight the intrinsic ability of 
BSA and casein to stabilize curcumin. 
 
CONCLUSION 
In brief, it can be suggested that “protein-
curcumin” complexes may be effective tools for 
curcumin delivery in vivo. This laboratory 
suggest that mixing of curcumin with milk or its 
consumption as albumin containing capsules 
may lead to more stability, bioavailability and 
therapeutic efficiency, in vivo. 
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